摘要
背景:在过去的几十年中,大量的抗惊厥药物已被纳入治疗癫痫的药物集合中。然而,治疗中的两个主要困难仍未解决:耐药性癫痫的发展和药物对反应性患者的严重毒性反应的发生。对发现已知抗惊厥药物的策略的回顾性分析表明,对癫痫动物模型的筛选活动几乎是识别已上市化合物的唯一策略。然而,关于抗惊厥药物分子靶点的实际结构和功能信息以及对引起癫痫发作的分子改变的日益了解,可以更合理地识别活性化合物。目标:本综述汇编了用于发现新的抗惊厥候选药物的基于目标的策略,分为两个主要主题。第一个概述了计算方法(基于对接的虚拟筛选和分子动力学)以寻找与电压门控离子通道和酶碳酸酐酶相互作用的抗惊厥结构。第二个包括分析合成的活性化合物,通过抗惊厥药物的药效团组合同时作用于不同的分子靶标。 结论:目前对抗惊厥药靶点结构的了解使计算模拟成为发现和优化活性化合物的有吸引力的方法。将通过虚拟筛选不同靶标所获得的结果结合起来,可以产生多靶标化合物,作为合并已知药物支架的结构设计的替代方案。
关键词: 抗惊厥药物、癫痫、电压门控离子通道、碳酸酐酶、对接、虚拟筛选、多靶点药物、混合分子。
Current Medicinal Chemistry
Title:Computational and Synthetic Target-based Approaches to the Discovery of Novel Anticonvulsant Compounds
Volume: 28 Issue: 33
关键词: 抗惊厥药物、癫痫、电压门控离子通道、碳酸酐酶、对接、虚拟筛选、多靶点药物、混合分子。
摘要:
Background: During the past decades, an important number of anticonvulsant drugs have been incorporated into the collection of drugs to treat epilepsy. However, two main difficulties remain unsolved in therapy: the development of drug-resistant epilepsy and the occurrence of severe toxic effects caused by the medication in responsive patients. The retrospective analysis of the strategies for discovering known anticonvulsant drugs showed that screening campaigns on animal models of epilepsy have been almost the exclusive strategy for identifying the marketed compounds. However, the actual structural and functional information about the molecular targets of the anticonvulsant drugs and the increasing knowledge of the molecular alterations that generate epileptic seizures allow a more rational identification of active compounds.
Objective: This review compiles target-based strategies used for the discovery of new anticonvulsant candidates and is divided in two main topics. The first one provides an overview of the computational approaches (docking-based virtual screening and molecular dynamics) to find anticonvulsant structures that interact with the voltage-gated ion channels and the enzyme carbonic anhydrase. The second one includes the analysis of active compounds synthesized to act simultaneously on different molecular targets by the combination of pharmacophores of anticonvulsant drugs.
Conclusion: Current knowledge of the architectures of anticonvulsant targets makes computational simulations attractive methods for the discovery and optimization of active compounds. Combining the results achieved by virtual screening of different targets could lead to multitarget compounds, as an alternative to the design of structures that merge scaffolds of known drugs.
Export Options
About this article
Cite this article as:
Computational and Synthetic Target-based Approaches to the Discovery of Novel Anticonvulsant Compounds, Current Medicinal Chemistry 2021; 28 (33) . https://dx.doi.org/10.2174/0929867328666210506161234
DOI https://dx.doi.org/10.2174/0929867328666210506161234 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Progress in Transition-Metal-Catalyzed C-N Cross-Couplings: Emerging Approaches Towards Sustainability
Current Organic Synthesis Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimers Disease
Current Medicinal Chemistry Therapeutic Potential of Voltage Gated Calcium Channels
Mini-Reviews in Medicinal Chemistry Transient Receptor Potential Vanilloid 1 and Xenobiotics
CNS & Neurological Disorders - Drug Targets Adult Neurogenesis in the Hypothalamus: Evidence, Functions and Implications
CNS & Neurological Disorders - Drug Targets Bioinformatic Screening of Autoimmune Disease Genes and Protein Structure Prediction with FAMS for Drug Discovery
Protein & Peptide Letters Update on the Slow Delayed Rectifier Potassium Current (IKs): Role in Modulating Cardiac Function
Current Medicinal Chemistry Pyrrolizidine Alkaloids and their Biological Properties from Indian Heliotropium Species
Current Bioactive Compounds Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry Valproate and Neuroendocrine Changes in Relation to Women Treated for Epilepsy and Bipolar Disorder: A Review
Current Medicinal Chemistry Differences in Relative Levels of 88 microRNAs in Various Regions of the Normal Adult Human Brain
MicroRNA Enantiopure 1,2,3-Triazolyl-β-amino Acids via Click Cycloaddition Reaction on Racemic Alkynyl Precursors Followed by Separation of Stereoisomers
Current Topics in Medicinal Chemistry The Role of T-Type Calcium Channels in Epilepsy and Pain
Current Pharmaceutical Design How to Find Candidate Drug-targets for Antiepileptogenic Therapy?
Current Neuropharmacology Spatiotemporal Modulation of Central Neural Pathway Underlying Acupuncture Action: A Systematic Review
Current Medical Imaging Systematic Comparison of the Performance of Different 2D and 3D Ligand-Based Virtual Screening Methodologies to Discover Anticonvulsant Drugs
Combinatorial Chemistry & High Throughput Screening Synthesis of Chromen-1-phenylpropan-1-one Derivatives and their Antidepressant/ Anticonvulsant Activities
Letters in Drug Design & Discovery Emerging Roles for Riboflavin in Functional Rescue of Mitochondrial β-Oxidation Flavoenzymes
Current Medicinal Chemistry Editorial [Hot topic: An Overview on the Design, Development, Characterization and Applications of Novel Nanomedicines for Brain Targeting (Guest Editor: Eliana B. Souto)]
Current Nanoscience Effect of Levetiracetam on Cognitive Function and Clonic Seizure Frequency in Children with Epilepsy
Current Molecular Medicine